126 related articles for article (PubMed ID: 12352460)
1. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
Isurugi K; Suzuki Y; Tanji S; Fujioka T
J Urol; 2002 Oct; 168(4 Pt 1):1574-7. PubMed ID: 12352460
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
4. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
[TBL] [Abstract][Full Text] [Related]
5. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M
Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
[TBL] [Abstract][Full Text] [Related]
7. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Koshida K; Namiki M; Inoue M
Clin Cancer Res; 1998 Nov; 4(11):2807-10. PubMed ID: 9829746
[TBL] [Abstract][Full Text] [Related]
8. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
9. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.
Eissa S; Motawi T; Badr S; Zaghlool A; Maher A
Clin Lab; 2013; 59(3-4):317-23. PubMed ID: 23724620
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.
Fukui T; Nonomura N; Tokizane T; Sato E; Ono Y; Harada Y; Nishimura K; Takahara S; Okuyama A
Mol Urol; 2001; 5(1):19-23. PubMed ID: 11689147
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
Xie XY; Yang X; Zhang JH; Liu ZJ
Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
15. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.
De Kok JB; Schalken JA; Aalders TW; Ruers TJ; Willems HL; Swinkels DW
Int J Cancer; 2000 Jul; 87(2):217-20. PubMed ID: 10861477
[TBL] [Abstract][Full Text] [Related]
16. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S
Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590
[TBL] [Abstract][Full Text] [Related]
17. Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.
Mezzasoma L; Antognelli C; Del Buono C; Stracci F; Cottini E; Cochetti G; Talesa VN; Mearini E
BMC Urol; 2010 Oct; 10():17. PubMed ID: 20920335
[TBL] [Abstract][Full Text] [Related]
18. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
[TBL] [Abstract][Full Text] [Related]
19. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
[TBL] [Abstract][Full Text] [Related]
20. Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.
Suzuki T; Suzuki Y; Fujioka T
J Urol; 1999 Dec; 162(6):2217-20. PubMed ID: 10569622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]